Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
| Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S |
| Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc. |
| 1:2022cv00114 |
| November 10, 2022 |
| US District Court for the Northern District of West Virginia |
| Thomas S Kleeh |
| Patent - Abbreviated New Drug Applications (ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 10, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 5 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (Copy Patent/Trademark Office) (jmm) |
| Filing 4 Corporate Disclosure Statement by H. Lundbeck A/S. (jmm) |
| Filing 3 Corporate Disclosure Statement by Otsuka Pharmaceutical Co., Ltd. (jmm) |
| Filing 2 SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. (jmm) |
| Filing 1 COMPLAINT against All Defendants, filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Filing Fee PAID $402 -. Receipt #AWVNDC-3590656. (Attachments: #1 Exhibit A US Patent 11,400,087 B2, #2 Civil Cover Sheet)(jmm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
